The therapeutic approach of the May-Thurner Syndrome without Deep Venous Thrombosis: a systematic review
May-Thurner Syndrome is a clinical condition which causes a variety of vascular symptoms, resulting from pelvic and lower extremity venous flow obstruction caused by the compression of the iliac vein by overlying iliac artery. Treatment paradigms have changed as experience with endovascular modalities has evolved, making traditional surgical treatment strategies essentially obsolete and a endovascular treatment with angioplasty and stenting along selective thrombolysis has become the standard for symptomatic the syndrome. The objective of this present study is to show the therapeutic approach in treatment when there’s no presence of Deep Venous Thrombosis (DVT) symptoms. To accomplish this purpose, a systematic review of articles about May-Thurner Syndrome and its management therapies, published from January 1, 2005 to September 20, 2015, on PubMED and SCOPUS databases, was carried out. Search terms were “may-thurner syndrome” (medical subject headings [MeSH term]), “iliocaval compression syndrome” (MeSH), “cockett syndrome” (MeSH), “peripheral vascular diseases” (MeSH), and “treatment” (keyword). Of the 89 retrieved studies, 14 met the elegibility criteria. Retrieved studies covered that without correction of this syndrome, patients are at continued risk for recurrent deep vein thrombosis and post-thrombotic syndrome. Considering the therapy, systemic anticoagulation is the first component, and endovascular treatment appears to be superior to conventional surgical treatment. It should be the first line of therapy. Furthermore, there has been multiple advences in the recent years for chronic arterial occlusions using techniques such as blunt micro dissection, radiofrequency energy and laser. In the absence of deep venous trombosis, conservative treatments are preferred. To conclude, based on the review of the literature, a combination of conservative and endovascular therapy usually provides the best treatment in most cases. Thus, further researches must be done to advance in the matter of therapeutic of the non-DVT form of May-Thurner Syndrome.
Keywords: May-Thurner Syndrome, Iliocaval Compression Syndrome, Cockett Syndrome, Peripheral Vascular Disease, Treatment.
2. Budnur SC, Singh B, Mahadevappa CN. Et al. Endovascular treatment of iliac vein compression syndrome (May–Thurner). Cardiovasc Interv and Ther. 2013; 28:101–105.
3. Hager ES, You T, Tahara R. Et al. Outcomes of endovascular intervention for May-Thurner syndrome. J Vasc Surg: Venous and Lym Dis. 2013; 1:270-5.
4. Murphy EH, Davis CM, Journeycake JM. Et al. Symptomatic ileofemoral DVT after onset of oral contraceptive use in women with previously undiagnosed May-Thurner Syndrome. J Vasc Surg. 2009; 49:697-703.
5. Pandit SA, Hayes M, Guiney-Borgelt S. Et al. Iatrogenic May- Thurner Syndrome After EVAR. Ann Vasc Surg. 2014; 28: 739.e17–739.e20.
6. Liu Z, Gao N, Shen L. Et al. Endovascular Treatment for Symptomatic Iliac Vein Compression Syndrome: A Prospective Consecutive Series of 48 Patients. Ann Vasc Surg. 2014; 28: 695–704.
7. Oguzkurt L, Tercan F, Sener M. Successful Endovascular Treatment of Iliac Vein Compression (May-Thurner) Syndrome in a Pediatric Patient. Cardiovasc Intervent Radiol. 2006; 29:446–449.
8. Ludwig B, Han T, Amundson D. Postthrombotic Syndrome Complicating a Case of May-Thurner Syndrome Despite Endovascular Therapy. CHEST. 2006; 129:1382–1386.
9. Loukas M. Et al. A case of May-Thurner syndrome. Folia Morphologica. 2008; 67: 214-217.
10. Suwanabol PA, Tefera G, Schwarze ML. Syndromes Associated With the Deep Veins: Phlegmasia Cerulea Dolens, May–Thurner Syndrome, and Nutcracker Syndrome. Perspectives in Vascular Surgery and Endovascular Therapy. 2010; 22(4) 223–230.
11. Smeds MR, Jacobs DL. Treatment of Chronic Venous Stent Occlusion With a Wildcat Catheter. Vascular and Endovascular Surgery. 2011; 45(5) 453-456.
12. Abboud G, Midulla M, Lions C. ‘‘Right-Sided’’ May-Thurner Syndrome. Cardiovasc Intervent Radiol. 2010; 33:1056–1059.
13. Mahnken AH, Thomson K, de Haan M, O’Sullivan GJ. CIRSE Standards of Practice Guidelines on Iliocaval Stenting. Cardiovasc Intervent Radiol. 2014; 37:889–897.
14. Knipp BS, Ferguson E, Williams DM. Factors associated with outcome after interventional treatment of symptomatic iliac vein compression syndrome. J Vasc Surg. 2007; 46:743-9.
Copyright policies & self-archiving
We are a RoMEO green journal.
Author's Pre-print: author can archive pre-print (ie pre-refereeing)
Author's Post-print: author can archive post-print (ie final draft post-refereeing)
Publisher's Version/PDF: author can archive publisher's version/PDF
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access and Benefits of Publishing Open Access).
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
Articles are published Under License of Creative Commons Attribution 4.0 License ©